Other Species / Isoforms
  EFNB2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y11-p
RRDSVWKyCWGVLMV
0 1
EFNB2 (human) RRDSVWKyCWGVLMV Y11-p
EFNB2 (mouse) RRDSVWKYCWGLLMV Y14
EFNB2 (rat) RRDSVWKYCWGLLMV Y14
N36
VLEPIYWNSSNSKFL
0 1
EFNB2 (human) VLEPIYWNSSNSKFL N36
EFNB2 (mouse) VLEPIYWnSSNSKFL N39-ng
EFNB2 (rat) VLEPIYWNSSNSKFL N39
T69-p
CPKVDSKtVGQYEYY
0 1
EFNB2 (human) CPKVDSKtVGQYEYY T69-p
EFNB2 (mouse) CPKVDSKTVGQYEYY T72
EFNB2 (rat) CPKVDSKTVGQYEYY T72
N139
YYIISTSNGSLEGLD
0 1
EFNB2 (human) YYIISTSNGSLEGLD N139
EFNB2 (mouse) YYIISTSnGSLEGLD N142-ng
EFNB2 (rat) YYIISTSNGSLEGLD N142
T180-ga
STRNKDPtRRPELEA
0 1
EFNB2 (human) STRNKDPtRRPELEA T180-ga
EFNB2 (mouse) SARNHGPTRRPELEA T183
EFNB2 (rat) STRNNDPTRRPELEA T183
T189-ga
RPELEAGtNGRSSTT
0 1
EFNB2 (human) RPELEAGtNGRSSTT T189-ga
EFNB2 (mouse) RPELEAGTNGRSSTT T192
EFNB2 (rat) RPELEAGTNGRSSTT T192
S260-p
RRRHRKHsPQHtTTL
Upstream
0 5
Treatment
  • angiotensin_2
  • LRRK2-IN-1
EFNB2 (human) RRRHRKHsPQHtTTL S260-p
EFNB2 (mouse) RRRHRKHSPQHTTTL S263
EFNB2 (rat) RRRHRKHSPQHTTTL S263
T264-p
RKHsPQHtTTLsLsT
0 1
EFNB2 (human) RKHsPQHtTTLsLsT T264-p
EFNB2 (mouse) RKHSPQHTTTLSLST T267
EFNB2 (rat) RKHSPQHTTTLSLST T267
S268-p
PQHtTTLsLsTLAtP
Upstream
0 2
Treatment
  • angiotensin_2
EFNB2 (human) PQHtTTLsLsTLAtP S268-p
EFNB2 (mouse) PQHTTTLSLSTLAtP S271
EFNB2 (rat) PQHTTTLSLSTLATP S271
S270-p
HtTTLsLsTLAtPKR
0 1
EFNB2 (human) HtTTLsLsTLAtPKR S270-p
EFNB2 (mouse) HTTTLSLSTLAtPKr S273
EFNB2 (rat) HTTTLSLSTLATPKR S273
T274-p
LsLsTLAtPKRSGNN
0 5
EFNB2 (human) LsLsTLAtPKRSGNN T274-p
EFNB2 (mouse) LSLSTLAtPKrGGNN T277-p
EFNB2 (rat) LSLSTLATPKRGGNN T277
R277
sTLAtPKRSGNNNGS
0 2
EFNB2 (human) sTLAtPKRSGNNNGS R277
EFNB2 (mouse) STLAtPKrGGNNNGS R280-m1
EFNB2 (rat) STLATPKRGGNNNGS R280
Y304-p
DSVFCPHyEKVsGDy
Upstream
Downstream
1 258
Effects on Modified Protein
  • molecular association, regulation
  • protein conformation
Treatment
  • ephrin_B1
  • ephrin_B2
  • HGF
  • Su11274
EFNB2 (human) DSVFCPHyEKVsGDy Y304-p
EFNB2 (mouse) DSVFCPHyEKVsGDy Y307-p
EFNB2 (rat) DSVFCPHyEKVSGDY Y307-p
S308-p
CPHyEKVsGDyGHPV
0 17
EFNB2 (human) CPHyEKVsGDyGHPV S308-p
EFNB2 (mouse) CPHyEKVsGDyGHPV S311-p
EFNB2 (rat) CPHyEKVSGDYGHPV S311
Y311-p
yEKVsGDyGHPVyIV
Upstream
Downstream
2 133
EFNB2 (human)
Y311-p
EFNB2 (mouse)
Y314-p
Effects on Modified Protein
  • protein conformation
  • protein stabilization
Treatment
  • erlotinib
  • FGF2
EFNB2 (human) yEKVsGDyGHPVyIV Y311-p
EFNB2 (mouse) yEKVsGDyGHPVyIV Y314-p
EFNB2 (rat) yEKVSGDYGHPVYIV Y314
Y316-p
GDyGHPVyIVQEMPP
Downstream
3 128
EFNB2 (human)
Y316-p
EFNB2 (mouse)
Y319-p
Effects on Modified Protein
  • protein conformation
  • protein stabilization
EFNB2 (human) GDyGHPVyIVQEMPP Y316-p
EFNB2 (mouse) GDyGHPVyIVQEMPP Y319-p
EFNB2 (rat) GDYGHPVYIVQEMPP Y319
Y330-p
PQSPANIyyKV____
Upstream
0 178
Treatment
  • EGF
  • erlotinib
EFNB2 (human) PQSPANIyyKV____ Y330-p
EFNB2 (mouse) PQSPANIyYKV____ Y333-p
EFNB2 (rat) PQSPANIYYKV____ Y333
Y331-p
QSPANIyyKV_____
0 35
EFNB2 (human) QSPANIyyKV_____ Y331-p
EFNB2 (mouse) QSPANIyYKV_____ Y334
EFNB2 (rat) QSPANIYYKV_____ Y334